中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2012年
53期
9903-9910
,共8页
李利华%于洪涛%贾金广%王敏%杜鹃
李利華%于洪濤%賈金廣%王敏%杜鵑
리리화%우홍도%가금엄%왕민%두견
重症肺炎%呼吸重症监护室%肾移植%临床特点%分析%免疫抑制%感染%甲基泼尼松龙%无创呼吸机%器官移植
重癥肺炎%呼吸重癥鑑護室%腎移植%臨床特點%分析%免疫抑製%感染%甲基潑尼鬆龍%無創呼吸機%器官移植
중증폐염%호흡중증감호실%신이식%림상특점%분석%면역억제%감염%갑기발니송룡%무창호흡궤%기관이식
背景:肾移植后重症肺炎发生率高,死亡率高,对其进行早期诊断及治疗具有重要意义.目的:分析呼吸重症监护室收治的肾移植后重症肺炎患者的临床特点、病情及预后,以提高其早期诊断率及治愈率.方法:对2004年1月至2012年9月郑州人民医院呼吸重症监护室收治的28例肾移植后出现重症肺炎的患者进行回顾性调查分析,总结其临床特点.应用急性生理学与慢性健康状况评分Ⅱ、英国胸科协会改良肺炎评分对患者病情进行评估,并给予适当的治疗.结果与结论:28例患者重症肺炎感染发生在肾移植后3-8个月,普遍应用免疫抑制剂的剂量较大;主诉有呼吸急促、干咳、胸闷、发热.血浆白蛋白下降明显,动脉血气分析均为低氧血症,低二氧化碳血症,动脉血氧饱和度进行性下降.胸部 CT 示肺部广泛渗出阴影.停用免疫抑制药物,并给予广谱抗感染药物、甲基泼尼松龙及无创呼吸机治疗后,治愈24例、好转2例、死亡2例.治疗期间患者肝、肾功能无恶化.提示肾移植后免疫抑制过度是并发重症肺炎的高危因素;重视体温监测,活动后气促及不明原因血清白蛋白下降有助于早期诊断.果断停用免疫抑制剂,并进行抗感染、甲基泼尼松龙及恰当无创呼吸机治疗是治疗成功的关键.
揹景:腎移植後重癥肺炎髮生率高,死亡率高,對其進行早期診斷及治療具有重要意義.目的:分析呼吸重癥鑑護室收治的腎移植後重癥肺炎患者的臨床特點、病情及預後,以提高其早期診斷率及治愈率.方法:對2004年1月至2012年9月鄭州人民醫院呼吸重癥鑑護室收治的28例腎移植後齣現重癥肺炎的患者進行迴顧性調查分析,總結其臨床特點.應用急性生理學與慢性健康狀況評分Ⅱ、英國胸科協會改良肺炎評分對患者病情進行評估,併給予適噹的治療.結果與結論:28例患者重癥肺炎感染髮生在腎移植後3-8箇月,普遍應用免疫抑製劑的劑量較大;主訴有呼吸急促、榦咳、胸悶、髮熱.血漿白蛋白下降明顯,動脈血氣分析均為低氧血癥,低二氧化碳血癥,動脈血氧飽和度進行性下降.胸部 CT 示肺部廣汎滲齣陰影.停用免疫抑製藥物,併給予廣譜抗感染藥物、甲基潑尼鬆龍及無創呼吸機治療後,治愈24例、好轉2例、死亡2例.治療期間患者肝、腎功能無噁化.提示腎移植後免疫抑製過度是併髮重癥肺炎的高危因素;重視體溫鑑測,活動後氣促及不明原因血清白蛋白下降有助于早期診斷.果斷停用免疫抑製劑,併進行抗感染、甲基潑尼鬆龍及恰噹無創呼吸機治療是治療成功的關鍵.
배경:신이식후중증폐염발생솔고,사망솔고,대기진행조기진단급치료구유중요의의.목적:분석호흡중증감호실수치적신이식후중증폐염환자적림상특점、병정급예후,이제고기조기진단솔급치유솔.방법:대2004년1월지2012년9월정주인민의원호흡중증감호실수치적28례신이식후출현중증폐염적환자진행회고성조사분석,총결기림상특점.응용급성생이학여만성건강상황평분Ⅱ、영국흉과협회개량폐염평분대환자병정진행평고,병급여괄당적치료.결과여결론:28례환자중증폐염감염발생재신이식후3-8개월,보편응용면역억제제적제량교대;주소유호흡급촉、간해、흉민、발열.혈장백단백하강명현,동맥혈기분석균위저양혈증,저이양화탄혈증,동맥혈양포화도진행성하강.흉부 CT 시폐부엄범삼출음영.정용면역억제약물,병급여엄보항감염약물、갑기발니송룡급무창호흡궤치료후,치유24례、호전2례、사망2례.치료기간환자간、신공능무악화.제시신이식후면역억제과도시병발중증폐염적고위인소;중시체온감측,활동후기촉급불명원인혈청백단백하강유조우조기진단.과단정용면역억제제,병진행항감염、갑기발니송룡급흡당무창호흡궤치료시치료성공적관건.
BACKGROUND: The incidence rate and the mortality of severe pneumonia after renal transplantation are high. So it has great significance to early diagnosis and treatment of severe pneumonia. OBJECTIVE: To analyze the clinical characteristics, pathogenetic condition and prognosis of severe pneumonia patients after renal transplantation treated in respiratory intensive care unit, in order to improve the early diagnosis rate and cure rate. METHODS: Twenty-eight severe pneumonia patients after renal transplantation treated in the respiratory intensive care unit of Zhengzhou People’s Hospital from January 2004 to September 2012 were investigated retrospectively, and the characteristics were summarized. The pathogenetic condition of the patients was evaluated with Acute Physiology and Chronic Health Evaluation treated appropriately. RESULTS AND CONCLUSION: The severe pneumonia infection in 28 patients occurred at 3-8 months after renal transplantation and most of the patients received larger immunosuppressant doses. The patients complaint of tachypnea, dry cough, chest tightness and fever. The plasma albumin of the severe pneumonia patients was significantly decreased; the arterial blood gas analysis showed the hypoxemia and low hypercapnia, and the arterial oxygen saturation was gradual y decreased. Chest CT showed that there was shadow secretion in the lung. Then the patients disable the immunosuppressive drugs, combined with anti-infection treatment and non-invasive ventilator, finding that 24 patients were cured, two patients were improved and two patients were dead. The liver function and renal function of patients were progression-free during treatment. Excessive immunosuppression after renal transplantation is the risk factor for severe pneumonia; great importance to the monitoring the body temperature after the event, shortness of breath and unexplained serum albumin decreasing are benefit to the early diagnosis. Decisively disable the immunosuppressive drugs combined with the broad-spectrum anti-infective drugs, methyl prednisolone and non-invasive ventilation therapy are the key to the successful treatment.